Opening remarks written by Eran Harary for the Israel HealthTech Digest by 8400: "Dear Partners, Colleagues, and Friends, As Passover approaches, let us reflect on our journey, where challenges serve as catalysts for growth, and innovation paves the way to a brighter future for all. Passover beautifully illustrates the power of community in transcending adversity. Teva's recent initiative to identify innovative technologies with the potential to strengthen Israel's mental health system, undertaken in collaboration with 8400, serves as a shining example of these two organizations' dedication to accelerating global cure by taking unique and creative approaches (read more about the initative HERE). This initiative exemplifies resilience and effectiveness in fostering positive change. Fueled by brainpower, determination, and scientific acumen, Israel is emerging from adversity with newfound strength. As members of the healthcare and biotech ecosystem, it is our shared responsibility to harness the collective power of our ecosystems to promote health universally. Let's bridge across boundaries to create meaningful changes that reach and benefit people across the globe. Eran Harary, MD, SVP Global Clinical Development, Teva Pharmaceuticals; 8400 Network Member" For the full issue: https://lnkd.in/dt6r6y-c]
8400 The Health Network’s Post
More Relevant Posts
-
On #WorldLipodystrophyDay it seems fitting to share patient journey's - created with input from global #PatientGroups in collaboration with Chiesi Group. Here is a typical #PatientJourney for #GeneralisedLipodystrophy #Lipodystrophy #RaisingAwareness #Research #TreatmentEquity #Care4Rare #RareDisease #PatientVoice #StrongerTogether
To view or add a comment, sign in
-
A fascinating couple of days LSX in London. There was no shortage of insight at the intersection of MedTech, BioTech and HealthTech for digital health. It was great to hear from speakers from Pharma like Gregoire Guillet from Servier, Beth Wolff from Lundbeck, Dominic James from MSD and Ventsislav Dobrev from our partner Ypsomed AG talking about the challenges and opportunities that Digital Health presents. Great insights too on the Medtech side from speakers like Thomas Hummel from Fresenius Kabi and Aneta Gawlowska from Medtronic. Key takeaways for me include: ✅ Everyone is still searching for the right Digital Health business models that are sustainable, scalable and ideally independent of the core medical device or drug revenue ✅ The fragmented healthcare ecosystem means that there are a lot of friction points that slow adoption; partnering across the ecosystem will be a key part of everyone's future strategy ✅ Start small but plan to be able to scale fast - platform strategies will be essential Thanks all for a great event!
To view or add a comment, sign in
-
On #WorldLipodystrophyDay it seems fitting to share patient journey's - created with input from global #PatientGroups in collaboration with Chiesi Group. Here is a typical #PatientJourney for #PartialLipodystrophy #Lipodystrophy #RaisingAwareness #Research #TreatmentEquity #Care4Rare #RareDisease #PatientVoice #StrongerTogether
To view or add a comment, sign in
-
📣 Stay in the know! 🌟 Join Parexel's LinkedIn community of more than 200,000 subscribers! "New Medicines, Novel Insights" biweekly articles bring you the latest updates, trends, and innovations shaping the future of clinical research. Read past articles, engage with industry experts, and be sure to subscribe to receive each new edition! #NovelInsights
To view or add a comment, sign in
-
📅 How is healthtech transforming clinical trials? Explore this topic at our upcoming Open Mic: Next in Health Series on integrating healthtech in clinical trials: smarter data collection & analysis. 👉 Sign up now: https://lnkd.in/e_4j7uYT In this session, you will: ✔️ Discuss the critical need for innovative technologies to streamline data collection and analysis in clinical trials ✔️ Learn strategies to protect patient data, ensure compliance, and foster trust throughout the trial process ✔️ Discover how high-quality data enables advanced analytics on larger datasets to derive additional value for patients ✔️ Engage with experts on accelerating trial timelines for robust outcomes in decision-making and regulatory filing ✔️ Network with professionals and exchange ideas on the future of healthcare ✔️ Enjoy an Apéro at the Novartis Pavillon On stage: Poorya Amini, CEO and Founder, Risklick Ieuan Clay, Director, Science, VivoSense, Inc. Mara Hummel, Senior Clinical Operations Lead Additional speaker to be announced soon! 💡 Don’t miss out on this opportunity to be part of the next wave of clinical trial innovation! Many thanks to Novartis for sponsoring the incredible location and Apéro. #healthtech #clinicaltrials #datacollection #dataanalysis #patientengagement #innovation
To view or add a comment, sign in
-
On March 5-6 2024, the annual health conference was held in Jerusalem and I as CEO of PharmaPrime, thanks to ITA - Italian Trade Agency, had the honor and privilege to participate in presenting the services that Pharmaprime offers and proposes to Companies having the interest and health of patients at heart. Pharmaprime has always been committed to creating innovative projects by combining technologies with digital health solutions to achieve the best results in therapeutics. MIXiii Health-Tech.IL showcase is the annual and international event held this year in Jerusalem where Life Science and Health Tech industries can come together to share new technologies and new discoveries in the field of health. The goal is to unite the Israeli tech ecosystem with other countries around the world to provide solutions and support at all levels and thus integrate the various sectors of industry with multinational R&D centers, Startups, Academic Institutions, Innovation Centers, hospitals, and the Government. This event is a showcase of the world of people's health and well-being and Research, effectively creating a network between the various sectors to improve and enhance services for the health of citizens. #healthcare #digitalhealth #Mixiii
To view or add a comment, sign in
-
Scaling is crucial in every industry, but the stakes are higher in clinical trials. By scaling effectively, we can ensure that more patients have access to innovative treatments and therapies, leading to improved health outcomes and quality of life. But where do you start? How can organizations navigate the complexities of scaling in clinical trials? Join me on March 20th, 11a EST/ 3p GMT as Nicole DuPont Latimer, CEO of Medrio, sits down with Khone Saysana and Walter S. of Roche to explore these questions and more. They will cover: 📈 The importance of adhering to standardized practices and protocols to enhance reliability, consistency, and successful outcomes. 🔬Strategies for achieving efficiencies through strategic scaling in drug development. 💼Insights into the future of clinical trials and how scaling will shape the landscape. Don't miss the opportunity to gain insights from industry leaders and experts. Click the link in my comments to register now and secure your spot! #ClinicalTrials #Scaling #Innovation
To view or add a comment, sign in
-
DTA is excited to enter a partnership with the Japan Digital Health Alliance (JaDHA). JaDHA is a cross-industry research organization dedicated to advancing the digital health sector in Japan. By fostering collaboration across various industries, JaDHA addresses the key challenges hindering the growth and adoption of digital health technologies. The alliance focuses on researching solutions and developing strategies to overcome barriers, with the goal of driving innovation and ensuring the effective integration of digital health services in society. DTA and JaDHA finalized this partnership at the 2024 DTA Summit. This collaboration is aimed at advancing the global adoption and understanding of digital therapeutics. This partnership will focus on raising awareness, sharing best practices, engaging in strategic conferences, and pursuing joint projects to accelerate regulatory approval and reimbursement pathways for DTx worldwide. Pictured: Andy Molnar Jessica Hauflaire Danny Kim, PharmD Anand Iyer Gaku Sakaguchi Satoshi Iwasaki Yousuke Miharu #DTA #DTAAPACPolicy #DTx #DigitalHealth #Medtech #digitaltherapeutics #medtechinnovations
To view or add a comment, sign in
-
Today I’ve attended the 100th birthday event by Roche on "Closing the healthcare gap" A few key takeaways to start the weekend: 1️⃣ Every 15 years, Roche adapts its entire portfolio to drive innovation and effectively bring it to patients. Research and innovation are vital in this process. 2️⃣ Collaboration is essential to bridge the silos between pharma and prevention, ensuring faster access to medicine and healthcare advancements. 🤝 3️⃣ With 50% of the world lacking basic healthcare access, the importance of prevention cannot be overstated. Involving the patient perspective early on and adopting technology are crucial steps forward. 4️⃣ Early diagnostics and data utilization hold the key to unlocking the full potential of healthcare, leading to improved clinical outcomes and cost benefits. 📊💉 5️⃣ Empowering patients with data ownership is pivotal in advancing healthcare delivery. These insights underscore the urgency to prioritize innovation, embrace prevention, harness the power of data, and foster collaboration for a more equitable healthcare landscape. Thank you for hosting this interesting morning Isabelle Decker Marie-José Borst #HealthcareInnovation #ClosingTheGap
To view or add a comment, sign in
-
Explore the rapidly expanding field of Medtech, a thriving industry that plays a crucial role in shaping our economy, enhancing healthcare, and driving innovation. Gain valuable insights by downloading our latest report today.
Medtech is a rapidly growing industry that contributes to our economy, health, and innovation. But how much do you know about it? Download our latest report to learn more 👉 https://bit.ly/4bHHkOs The report features insights by RSM Australia's Jayesh Kapitan, Dr Rita Choueiri, Don Holley, Srdjan Dragutinovic, and Rebecca Barnes, as well as key leaders in the local and international medtech sector. Trajan Scientific and Medical Osteopore (OSX.AX) Mach7 Technologies Specialised Therapeutics #RSMAustralia #Medtech #Healthcare #Innovation
To view or add a comment, sign in
11,871 followers